Literature DB >> 17880640

Epidemiology of autism spectrum disorder in Portugal: prevalence, clinical characterization, and medical conditions.

Guiomar Oliveira1, Assunção Ataíde, Carla Marques, Teresa S Miguel, Ana Margarida Coutinho, Luísa Mota-Vieira, Esmeralda Gonçalves, Nazaré Mendes Lopes, Vitor Rodrigues, Henrique Carmona da Mota, Astrid Moura Vicente.   

Abstract

The objective of this study was to estimate the prevalence of autistic spectrum disorder (ASD) and identify its clinical characterization, and medical conditions in a paediatric population in Portugal. A school survey was conducted in elementary schools, targeting 332,808 school-aged children in the mainland and 10,910 in the Azores islands. Referred children were directly assessed using the Diagnostic and Statistical Manual of Mental Disorders (4th edn), the Autism Diagnostic Interview-Revised, and the Childhood Autism Rating Scale. Clinical history and a laboratory investigation was performed. In parallel, a systematic multi-source search of children known to have autism was carried out in a restricted region. The global prevalence of ASD per 10,000 was 9.2 in mainland, and 15.6 in the Azores, with intriguing regional differences. A diversity of associated medical conditions was documented in 20%, with an unexpectedly high rate of mitochondrial respiratory chain disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880640     DOI: 10.1111/j.1469-8749.2007.00726.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  31 in total

Review 1.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

2.  Mitochondrial and ion channel gene alterations in autism.

Authors:  Moyra Smith; Pamela L Flodman; John J Gargus; Mariella T Simon; Kimberley Verrell; Richard Haas; Gail E Reiner; Robert Naviaux; Katherine Osann; M Anne Spence; Douglas C Wallace
Journal:  Biochim Biophys Acta       Date:  2012-04-17

3.  Medial Frontal Lobe Neurochemistry in Autism Spectrum Disorder is Marked by Reduced N-Acetylaspartate and Unchanged Gamma-Aminobutyric Acid and Glutamate + Glutamine Levels.

Authors:  Andreia Carvalho Pereira; Inês R Violante; Susana Mouga; Guiomar Oliveira; Miguel Castelo-Branco
Journal:  J Autism Dev Disord       Date:  2018-05

4.  Language Predictors in Autism Spectrum Disorder: Insights from Neurodevelopmental Profile in a Longitudinal Perspective.

Authors:  Susana Mouga; Bárbara Regadas Correia; Cátia Café; Frederico Duque; Guiomar Oliveira
Journal:  J Abnorm Child Psychol       Date:  2020-01

5.  15q11.2-13 duplication, mitochondrial dysfunction, and developmental disorders.

Authors:  Richard E Frye
Journal:  J Child Neurol       Date:  2009-06-17       Impact factor: 1.987

6.  Operationalisation of the European Protocol for Autism Prevalence (EPAP) for Autism Spectrum Disorder Prevalence Measurement in Ireland.

Authors:  A M Boilson; A Staines; A Ramirez; M Posada; M R Sweeney
Journal:  J Autism Dev Disord       Date:  2016-09

Review 7.  The role of epilepsy and epileptiform EEGs in autism spectrum disorders.

Authors:  Sarah J Spence; Mark T Schneider
Journal:  Pediatr Res       Date:  2009-06       Impact factor: 3.756

Review 8.  Autoimmunity in autism.

Authors:  Amanda M Enstrom; Judy A Van de Water; Paul Ashwood
Journal:  Curr Opin Investig Drugs       Date:  2009-05

9.  Adaptive profiles in autism and other neurodevelopmental disorders.

Authors:  Susana Mouga; Joana Almeida; Cátia Café; Frederico Duque; Guiomar Oliveira
Journal:  J Autism Dev Disord       Date:  2015-04

10.  Differences in autism spectrum disorders incidence by sub-populations in Israel 1992-2009: a total population study.

Authors:  Raanan Raz; Marc G Weisskopf; Michael Davidovitch; Ofir Pinto; Hagai Levine
Journal:  J Autism Dev Disord       Date:  2015-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.